Please use the search below. See our frequently asked questions regarding clinical trials.
Showing 1 - 10 of 196
3300 Gallows Road
Falls Church, VA 22042
This study is a US-based, prospective, double-blind, multicenter, placebo-controlled, randomized 1:1, pulmonary hypertension in LVAD patients trial.
This is a US, multicenter, placebo-controlled, HFrEF trial. Testing Entresto in patients with any history of NYHA IV symptoms. 26-week study to assess change in NT-proBNP. Sponsor: NIH HF Network.
Heart failure and Diabetes share a common set of risk factors and both require ongoing lifestyle modification and adherence to complex medication regiments in order to achieve optimal outcomes. The study evaluates the utility of an mHealth (a mobile support of health related behaviors) intervention to improve physical activity and medication adherence in patients with both chronic heart failure and diabetes mellitus.
Showing 1 - 10 of 196
Randomized Phase 2 Trial Evaluating the Addition of the IGF-lR Monoclonal Antibody Ganitumab (AMG479, NSC#750008, IND#120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
Randomized Phase 2 Trial Evaluating the Addition of the IGF-lR Monoclonal Antibody Ganitumab (AMG479, NSC#750008, IND#120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing SarcomaNeuroblastoma Classification Biology Studies
Neuroblastoma Classification Biology Studieshttps://inova.org/clinical-trials/neuroblastoma-classification-biology-studies
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma
Inova Children's Hospital3300 Gallows Road
Falls Church, VA 22042
A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma SpecimensSoprano
This trial seeks to evaluate the efficacy of Macitentan in patients with pulmonary hypertension after left-ventricular device (LVAD) implantation.This study is a US-based, prospective, double-blind, multicenter, placebo-controlled, randomized 1:1, pulmonary hypertension in LVAD patients trial.
LIFE
This study seeks to evaluate the effectiveness of sacubatril-valsartan (aka: Entresto) in patients with advanced heart failure.This is a US, multicenter, placebo-controlled, HFrEF trial. Testing Entresto in patients with any history of NYHA IV symptoms. 26-week study to assess change in NT-proBNP. Sponsor: NIH HF Network.
Technology to improve drug Adherence and Reinforce Guideline based Exercise Targets in patients with Heart Failure and Diabetes Mellitus (TARGET-HF-DM)
Sponsor: American Heart Association and Duke MedicineHeart failure and Diabetes share a common set of risk factors and both require ongoing lifestyle modification and adherence to complex medication regiments in order to achieve optimal outcomes. The study evaluates the utility of an mHealth (a mobile support of health related behaviors) intervention to improve physical activity and medication adherence in patients with both chronic heart failure and diabetes mellitus.
DCM Precision Medicine Study
The purpose of this study is to identify gene changes that cause DCM and gene differences that influence the development and severity of DCM. These genetic studies may identify a change in a gene that has already been linked with DCM, a change in a gene not previously associated with DCM, or these studies may identify a gene or genes that affect the development and severity of the DCM. With this knowledge we hope to have a better understanding of how genes and gene changes cause DCM.https://inova.org/clinical-trials/dcm-precision-medicine-study